$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
预防结直肠癌,你需要知道的事儿!
2025-10-19 11:44:20
Check Details
瑞格非尼在国内上市后售价多少一盒?
2025-10-19 11:44:20
Check Details
【你关心的】西妥昔单抗注射液价格多少钱?哪里有卖?
2025-10-19 11:44:20
Check Details
西妥昔单抗是化疗药吗?西妥昔单抗怎么购买?
2025-10-19 11:44:20
Check Details
FOLFIRINOX新辅助治疗方案可改善晚期直肠癌的疾病控制
2025-10-19 11:44:20
Check Details
含糖饮料可能使50岁以下女性患肠癌的风险增加一倍
2025-10-19 11:44:20
Check Details
2021年瑞格非尼进医保了吗?瑞格非尼报销后自己花多少钱?
2025-10-19 11:44:20
Check Details
靶向药雷莫芦单抗2021年多少钱一支?雷莫芦单抗纳入国家医保了吗?
2025-10-19 11:44:20
Check Details
雷莫芦单抗能作为转移性结直肠癌的二线疗法吗?
2025-10-19 11:44:20
Check Details
【最多阅览】雷莫芦单抗是安维汀治疗转移性结直肠癌失败后的选择吗?
2025-10-19 11:44:20
Check Details
新药曲氟尿苷替匹嘧啶片属于医保可报销药品吗?
2025-10-19 11:44:20
Check Details
曲氟尿苷替匹嘧啶片进入医保了吗?医保给报销吗?
2025-10-19 11:44:20
Check Details
1
2
...
7680
7681
7682
7683
7684
7685
7686
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
2
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
3
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
4
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
5
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
6
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
7
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
8
Adagrasib Medication Management Guide for Special Populations
9
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
10
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
11
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
12
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition